selected terms: 409 page 1 of 5

1. (gamma)
[The gamma-distribution used for data that is skewed and bounded to the right, i.e. where the maximum of the distribution curve is located near the origin. The g-distribution has a two parameters a and b. The relationship to mean m and variance s2 is m = a b and s2 = a b2. ( HL7V3.0 )] (UMLS (HL7) C1552644) =Intellectual Product =ProbabilityDistributionType;
51. Galanin Receptor 2 Gene
[This gene plays a role in cellular signal transduction through the phospholipase C/protein kinase C pathway. ( NCI )] (UMLS (NCI) C1333658) GALR2;
GALR2 Gene;
=Gene or Genome ;
2. .gamma.-(p-bis(2-chloroethyl)aminophenyl)butyric acid
[nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others; may be a carcinogen. ( CSP )] (UMLS (NCI) C0008163) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance =[AN000] ANTINEOPLASTICS;
Nitrogen Mustard Compound;
Antineoplastic Alkylating Agent;
haloalkylamine =CHLORAMBUCIL 2 MG;
52. Galectin 3 Binding Protein
[Widely expressed and encoded by human LGALS3BP Gene (MSR1 Superfamily), 585-amino acid extracellular Galectin 3 Binding Protein contains an N-terminal MSR1 Cys-rich domain and binds LGALS3 via carbohydrate-specific interaction. MAC2BP is a potent stimulator of host immune defense systems, such as NK and LAK cell cytotoxicity, and can induce IL2 cytokine production. Oncogenic transformation, viral infection, or pathogen invasion enhance MAC2BP production. LGALS3BP is elevated in the serum of cancer and HIV patients. (from LocusLink, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0217525) =Amino Acid, Peptide, or Protein; Immunologic Factor; Indicator, Reagent, or Diagnostic Aid
3. 14G2A
[A murine monoclonal antibody directed against the ganglioside GD2 with potential antineoplastic activity. Monoclonal antibody 14G2A binds to the ganglioside GD2 and induces antibody-dependent cell mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells. GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung. (NCI04) ( NCI )] (UMLS (NCI) C0280838) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
53. Galena Village (aka Louden Village)
(UMLS (HL7) C1550861) =Population Group =NativeEntityAlaska;
4. G Alpha Interacting Protein
[Expressed most in lung, placenta, liver, and heart by human RGS19 Gene (RGS Family), membrane-bound fatty acylated 217-aa 25-kDa Regulator of G-protein Signaling 19 is a guanosine triphosphatase-activating protein, containing 1 RGS domain, that specifically interacts with G protein GAI3 and down-regulates G Alpha i/G Alpha q-linked signaling. Heavily palmitoylated in the Cys string motif and mainly phosphorylated on Ser residues, RGS19 inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, driving them into the inactive GDP-bound form. RGS19 binds to G-Alpha subfamily 1 members and interacts with GIPC PDZ domain. (NCI) ( NCI )] (UMLS (NCI) C0384780) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
54. Gall Bladder
[storage reservoir for bile secretion; allows the delivery of bile acids at a high concentration and in a controlled manner, via the cystic duct to the duodenum, for degradation of dietary lipid. ( CSP )] (UMLS (HL7) C0016976) =Body Part, Organ, or Organ Component ;
=Bile Tract;
Body Part
5. G Antigen Family D, Protein 3
[Expressed in testis and placenta by human GAGED3 Gene (GAGE Family, CT Family), 111-aa 12-kD XAGE3 Protein has unknown function and shares similarity with GAGE/PAGE proteins, as well as with Pyridoxal-Dependent Decarboxylase Conserved Domain (C. elegans) and Larval Locomotory Behavior Glutamate Decarboxylase (Drosophila). (NCI) ( NCI )] (UMLS (NCI) C1333657) GAGED3;
GAGED3 Protein;
XAGE-2 Protein;
XAGE3 Protein;
XAGE-3 Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance
[synthetic nondepolarizing blocking drug. ( CSP )] (UMLS (NCI) C0016972) =Organic Chemical; Pharmacologic Substance =ammonium compound;
quaternary ammonium compound;
6. G-actin
(UMLS (NCI) C0016890) =Amino Acid, Peptide, or Protein; Biologically Active Substance
[ ] (UMLS (ICD9CM) C0176904) =Therapeutic or Preventive Procedure
7. GA
[A country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea. (NCI) ( NCI )] (UMLS (NCI) C0016910) =Geographic Area ;
◊ [A country in Western Africa, bordering the North Atlantic Ocean and Senegal. (NCI) ( NCI )] (UMLS (NCI) C0016993) Geographic Area ; ◊ [A state in the southeastern United States. Its capital is Atlanta. ( NCI )] (UMLS (NCI) C0017452) Geographic Area
57. Gallbladder Body
(UMLS (NCI) C0227545) =Body Part, Organ, or Organ Component
8. Ga
[rare, metallic element; symbol Ga, atomic number 31, and atomic weight 69.72. ( CSP )] (UMLS (NCI) C0016980) =Element, Ion, or Isotope ;
=heavy metal;
=gallium chloride;
Gallium nitrate;
gallium citrate
58. gallbladder cancer
[Primary or metastatic malignant neoplasm of the gallbladder. ( NCI )] (UMLS (CSP) C0153452) =Neoplastic Process
9. Ga67 isotope
[ ] (UMLS (CSP) C0599272) =Element, Ion, or Isotope
59. Gallbladder Cancer Stage I
[Stage I includes: IA: (T1, N0, M0); IB: (T2, N0, M0). T1: Tumor invades lamina propria or muscle layer. T1a: Tumor invades lamina propria. T1b: Tumor invades muscle layer. N0: No regional metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C1167716) Gallbladder Carcinoma Stage I;
Stage I Carcinoma of Gallbladder;
Stage I Carcinoma of the Gallbladder;
Stage I Gallbladder Cancer;
Stage I Gallbladder Carcinoma =Neoplastic Process
10. Ga68 isotope
[ ] (UMLS (CSP) C0599273) =Element, Ion, or Isotope
60. Gallbladder Cancer Stage II
[Stage II includes: IIA: (T3, N0, M0); IIB: (T1, N0, M0); (T2, N0, M0); (T3, N0, M0). T2: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, or pancreas, omentum or extrahepatic bile ducts. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C1142296) Gallbladder Carcinoma Stage II;
Stage II Carcinoma of Gallbladder;
Stage II Carcinoma of the Gallbladder;
Stage II Gallbladder Cancer;
Stage II Gallbladder Carcinoma =Neoplastic Process
11. GAB2
[GRB2-Associated Binding Protein 2 (GAB2), encoded by the human GAB2 gene, is the principal activator of phosphatidylinositol-3 kinase in response to activation of the high affinity IgE receptor. Upon tyrosine phosphorylation, GAB2 interacts with SHP2 tyrosine phosphatase and GRB2 adapter protein. It is the limiting component of the GAB2-SHP2 complex, signaling Erk MAP kinase activation and terminal differentiation of K562 CML cells. GAB2 also has an inhibitory effect on the activation of ELK1-dependent transcription triggered by a dominant active Ras mutant or under growth factor stimulation. Two alternatively spliced transcripts encode different isoforms and the short isoform is the main isoform. This protein is overexpressed and estrogen regulated in human breast cancer. (From LocusLink, OMIM and NCI) ( NCI )] (UMLS (NCI) C0387800) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
61. Gallbladder Cancer Stage III
[Stage III includes: (T4, Any N, M0). T4: Tumor invades main portal vein or hepatic artery or invades multiple extrahepatic organs or structures. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C1141952) Gallbladder Carcinoma Stage III;
Stage III Carcinoma of Gallbladder;
Stage III Carcinoma of the Gallbladder;
Stage III Gallbladder Cancer;
Stage III Gallbladder Carcinoma =Neoplastic Process
12. GAB2
[This gene plays a role in signal transduction and regulates T-cell proliferation. It is also involved in bone homeostasis and mediates the differentiation of progenitor cells into osteopaths. ( NCI )] (UMLS (NCI) C1333653) GAB2 Gene;
GRB2-Associated Binding Protein 2 Gene;
=Gene or Genome ;
62. Gallbladder Cancer Stage IV
[Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C1141953) Gallbladder Carcinoma Stage IV;
Stage IV Carcinoma of Gallbladder;
Stage IV Carcinoma of the Gallbladder;
Stage IV Gallbladder Cancer;
Stage IV Gallbladder Carcinoma =Neoplastic Process
13. GABA aminotransferase
[An enzyme that converts brain gamma-aminobutyric acid (GAMMA-AMINOBUTYRIC ACID) into succinate semialdehyde, which can be converted to succinic acid and enter the citric acid cycle. It also acts on beta-alanine. EC ( MSH )] (UMLS (CSP) C0002543) =Amino Acid, Peptide, or Protein; Enzyme ;
63. Gallbladder Cancer Stage IVA
(UMLS (NCI) C1168199) Gallbladder Carcinoma Stage IVA;
Stage IVA Carcinoma of Gallbladder;
Stage IVA Carcinoma of the Gallbladder;
Stage IVA Gallbladder Cancer;
Stage IVA Gallbladder Carcinoma =Neoplastic Process
14. GABA receptor
[regulate a family of transmembrane chloride channels such that binding of GABA or its analogs permits increased chloride influx, membrane hyperpolarization, and inhibition of postsynaptic electrical activity. ( CSP )] (UMLS (CSP) C0206518) =Amino Acid, Peptide, or Protein; Receptor =neurotransmitter receptor;
chloride channel
64. Gallbladder Cancer Stage IVB
(UMLS (NCI) C1168200) Gallbladder Carcinoma Stage IVB;
Stage IVB Carcinoma of Gallbladder;
Stage IVB Carcinoma of the Gallbladder;
Stage IVB Gallbladder Cancer;
Stage IVB Gallbladder Carcinoma =Neoplastic Process
15. GAC1
[Glioma Amplified on Chromosome 1 Protein, encoded by the human GAC1 gene, belongs to the leucine-rich repeat superfamily. This gene was found to be amplified and overexpressed in malignant gliomas. GAC1 has homology with other proteins that function as cell-adhesion molecules or as signal transduction receptors and is a candidate for the target gene in the 1q32.1 amplicon in malignant gliomas. (From LocusLink and NCI) ( NCI )] (UMLS (NCI) C1308623) Glioma Amplification on Chromosome 1;
Glioma Amplified on Chromosome 1 Protein;
Glioma Amplified on Chromosome 1 Protein (Leucine-Rich);
Leucine Rich Repeat Neuronal 5 Protein;
LRRN5 =Amino Acid, Peptide, or Protein; Biologically Active Substance
65. Gallbladder Cancer Unresectable
[Cancer that has spread to the tissues around the gallbladder (such as the liver, stomach, pancreas, intestine, or lymph nodes in the area) and cannot be surgically removed. ( NCI )] (UMLS (NCI) C0278807) =Neoplastic Process
16. GADD45 Gene Product
[Growth Arrest and DNA-Damage-Inducible, Alpha, encoded by the GADD45A gene, is widely expressed in normal tissues and its expression is increased by DNA damage. The DNA damage-induced transcription of this gene is mediated by both p53-dependent and -independent mechanisms. The GADD45A protein responds to environmental stresses by mediating activation of the p38/JNK pathway via MTK1/MEKK4 kinase. This nuclear protein interacts with the proliferating cell nuclear antigen (PCNA), a component of DNA replication/repair complexes, and the cyclin dependent kinase inhibitor p21Cip1. ( NCI )] (UMLS (NCI) C1098917) GADD45A;
GADD45A Protein;
Growth Arrest and DNA Damage-Inducible Gene 45 Protein;
Growth Arrest and DNA-Damage-Inducible, Alpha =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
66. Gallbladder Cancer, Localized
[Cancer found only in the tissues that make up the wall of the gallbladder. Localized gallbladder cancer can be removed completely in an operation. ( NCI )] (UMLS (NCI) C0877355) Localized Cancer of Gallbladder;
Localized Cancer of the Gallbladder;
localized gallbladder cancer;
Localized Gallbladder Carcinoma;
=Neoplastic Process
17. GADD45A
[This gene plays a role in signal transduction and is induced in response to environmental stress. It is involved in apoptosis, DNA repair and negative regulation of cell growth. ( NCI )] (UMLS (NCI) C1333655) GADD45A Gene;
Growth Arrest and DNA-Damage-Inducible, Alpha Gene;
=Gene or Genome ;
67. Gallbladder Cancer, Recurrent
[The reemergence of gall bladder cancer after a period of remission. ( NCI )] (UMLS (NCI) C0877357) Recurrent Cancer of Gallbladder;
Recurrent Cancer of the Gallbladder;
Recurrent Gallbladder Cancer;
Recurrent Gallbladder Carcinoma;
Relapsed Cancer of Gallbladder;
Relapsed Cancer of the Gallbladder;
Relapsed Gallbladder Cancer =Neoplastic Process
(UMLS (NCI) C0082646) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=Gadolinium DTPA;
Inactive Ingredient Preparations =GADODIAMIDE 287 MG/ML;
68. Gallbladder Epithelium
(UMLS (NCI) C1180206) =Tissue ;
19. gadolinium
[element of the rare earth family of metals, atomic symbol Gd, atomic number 64, and atomic weight 157.25; chelated gadolinium is used as a paramagnetic contrast agent in magnetic resonance imaging, and Gd153 is used in dual photon absorptiometry. ( CSP )] (UMLS (CSP) C0016911) =Pharmacologic Substance; Element, Ion, or Isotope =Metals, Rare Earth;
69. Gallbladder Fundus
(UMLS (NCI) C0227544) =Body Part, Organ, or Organ Component
20. Gadolinium Texaphyrin
[A substance that makes tumor cells more sensitive to radiation; it can also enhance tumor images using magnetic resonance imaging (MRI). Motexafin gadolinium belongs to the family of drugs called metalloporphyrin complexes. Also called gadolinium texaphyrin. ( NCI )] (UMLS (NCI) C0964264) Gd (III) Texaphryin;
Motexafin Gadolinium =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
70. Gallbladder Hyperplastic Polyp
(UMLS (NCI) C1333743) Hyperplastic Polyp of Gallbladder;
Hyperplastic Polyp of the Gallbladder =Disease or Syndrome ;
(UMLS (NCI) C0060930) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=Heterocyclic Compound;
Organometallic Compound;
71. Gallbladder Injury
(UMLS (NCI) C0434028) =Injury or Poisoning
22. Gadoversetamide
[A paramagnetic extracellular magnetic resonance imaging (MRI) contrast agent that facilitates visualization of abnormal vascularity. When placed in a magnetic field, gadoversetamide decreases T1 (spin-lattice or longitudinal relaxation time) and T2 (spin-spin or transverse relaxation time) values in tissues where it accumulates. At the recommended dose, the effect is primarily on T1 relaxation time, and produces an increase in signal intensity. Gadoversetamide does not cross the intact blood-brain barrier. However, abnormal vascularity or disruption of the blood-brain barrier allows accumulation of gadoversetamide. (NCI05) ( NCI )] (UMLS (NCI) C0754820) GADOVERSETAMIDE PREPARATION =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
72. Gallbladder Kaposi Sarcoma
[A Kaposi sarcoma arising from the gallbladder. ( NCI )] (UMLS (NCI) C1333744) Gallbladder Kaposi's Sarcoma;
Kaposi's Sarcoma of Gallbladder;
Kaposi's Sarcoma of the Gallbladder;
=Neoplastic Process ;
23. GAG
[DNA sequences that form the coding region for proteins associated with the viral core in retroviruses. gag is short for group-specific antigen. ( MSH )] (UMLS (NCI) C0017346) =Gene or Genome
73. Gallbladder Leiomyoma
[A benign smooth muscle neoplasm arising from the gallbladder. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. ( NCI )] (UMLS (NCI) C1333745) Leiomyoma of Gallbladder;
Leiomyoma of the Gallbladder =Neoplastic Process ;
24. gag gene related protein
[ ] (UMLS (CSP) C0751607) =Amino Acid, Peptide, or Protein; Biologically Active Substance
74. Gallbladder Leiomyosarcoma
[An aggressive malignant smooth muscle neoplasm, arising from the gallbladder. It is characterized by a proliferation of neoplastic spindle cells. ( NCI )] (UMLS (NCI) C1333746) Leiomyosarcoma of Gallbladder;
Leiomyosarcoma of the Gallbladder =Neoplastic Process ;
25. GAG Protein
[retroviral protein encoded by the gag gene; gag refers to group- specific antigen. ( CSP )] (UMLS (NCI) C0017279) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Viral Protein;
75. Gallbladder Lipoma
[A benign adipose tissue neoplasm involving the gallbladder wall. ( NCI )] (UMLS (NCI) C1333747) Lipoma of Gallbladder;
Lipoma of the Gallbladder =Neoplastic Process ;
26. gag(glycosaminoglycan)
[polymers of alternating sugar acids and aminosugars, which may be sulfated or otherwise further substituted; contribute to adhesion, elasticity, viscosity, etc., of extracellular substances. ( CSP )] (UMLS (CSP) C0017973) =Carbohydrate; Biologically Active Substance ;
heparan sulfate;
Hyaluronic Acid
76. Gallbladder Lymphoma
(UMLS (NCI) C1333748) Lymphoma of Gallbladder;
Lymphoma of the Gallbladder;
Primary Gallbladder Lymphoma;
=Neoplastic Process ;
27. gagging
[Clinical manifestation of the digestive system consisting of contraction of the muscle of the pharynx caused by stimulation of sensory receptors on the soft palate, by psychic stimuli, or systemically by drugs. ( MSH )] (UMLS (CSP) C0016927) =Finding ;
=gastrointestinal sign/symptom;
77. Gallbladder Malignant Melanoma
(UMLS (NCI) C1333749) Gallbladder Melanoma;
Malignant Melanoma of Gallbladder;
Malignant Melanoma of the Gallbladder;
Melanoma of Gallbladder;
Melanoma of the Gallbladder;
=Neoplastic Process ;
28. gait
[manner of running, walking, or moving on foot; applicable to humans or animals. ( CSP )] (UMLS (CSP) C0016928) =Finding ;
=chordate locomotion;
78. Gallbladder Neck
(UMLS (NCI) C0227546) =Body Part, Organ, or Organ Component
29. GAL-8
[Constitutively and ubiquitously expressed by human LGALS8 Gene (S-Lectin Family), 316-amino acid 35.5-kD extracellular Galectin 8 contains two carbohydrate-binding (recognition) domains (CRDs) and binds to beta galactoside in cell adhesion, cell cycle regulation, inflammation, immunomodulation, apoptosis, and metastasis. Galectin 8 may be involved in activation of various cell types through cross-linkage of cell surface glycoproteins and may be involved in some types of cancer. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1098710) Galectin 8;
Lectin, Galactoside-Binding, Soluble, 8;
LGALS8 Protein;
Po66 Carbohydrate Binding Protein;
PO66 Carbohydrate-Binding Protein;
Prostate Carcinoma Tumor Antigen;
Prostate Carcinoma Tumor Antigen 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
79. Gallbladder Neoplasm
[Abnormal growth of the cells that comprise the gall bladder. ( NCI )] (UMLS (NCI) C0016978) =Neoplastic Process ;
=Biliary Neoplasm;
Unspecified disorder of gallbladder
30. galactan
[polymers composed of galactose residues and occurring in plants, for example, agar. ( CSP )] (UMLS (CSP) C0016932) =Carbohydrate ;
hexosan =carrageenan;
guar gum
80. Gallbladder Neurofibroma
[A non-metastasizing encapsulated neoplasm arising from nerves in the gallbladder. Morphologically, it is characterized by the presence of fibroblasts and schwann cells. ( NCI )] (UMLS (NCI) C1333751) Neurofibroma of Gallbladder;
Neurofibroma of the Gallbladder =Neoplastic Process ;
31. galactitol
[A naturally occurring product of plants obtained following reduction of GALACTOSE. It appears as a white crystalline powder with a slight sweet taste. It may form in excess in the lens of the eye in GALACTOSEMIAS, a deficiency of GALACTOKINASE. ( MSH )] (UMLS (CSP) C0013283) =Carbohydrate; Biologically Active Substance ;
81. Gallbladder Oat Cell Carcinoma
(UMLS (NCI) C1333759) Gallbladder Small Cell Carcinoma;
Oat Cell Carcinoma of Gallbladder;
Oat Cell Carcinoma of the Gallbladder;
Small Cell Carcinoma of Gallbladder;
Small Cell Carcinoma of the Gallbladder;
=Neoplastic Process
(UMLS (ICD9CM) C0152243) =Acquired Abnormality; Disease or Syndrome
82. Gallbladder Pancreatic Heterotopia
(UMLS (NCI) C1333752) =Finding ;
33. galactokinase
[An enzyme that catalyzes reversibly the formation of galactose 1-phosphate and ADP from ATP and D-galactose. Galactosamine can also act as the acceptor. A deficiency of this enzyme results in GALACTOSEMIA. EC ( MSH )] (UMLS (CSP) C0016937) =Amino Acid, Peptide, or Protein; Enzyme =alcohol phosphotransferase;
83. Gallbladder Papillary Adenocarcinoma
(UMLS (NCI) C1333753) Papillary Carcinoma of Gallbladder;
Papillary Carcinoma of the Gallbladder =Neoplastic Process
34. galactolipid
[group of glycolipids in which the sugar group is galactose; distinguished from glycosphingolipids in lacking nitrogen; constitute the majority of membrane lipids in plants. ( CSP )] (UMLS (CSP) C0596591) =Lipid =glycolipid;
84. Gallbladder Papillomatosis
(UMLS (NCI) C1333754) =Neoplastic Process
35. galactorrhea
[ ] (UMLS (CSP) C0269995) =Disease or Syndrome
85. Gallbladder Pleomorphic Spindle and Giant Cell Adenocarcinoma
(UMLS (NCI) C1333755) Pleomorphic Spindle and Giant Cell Adenocarcinoma of Gallbladder;
Pleomorphic Spindle and Giant Cell Adenocarcinoma of the Gallbladder =Neoplastic Process
36. Galactorrhea, antepartum condition or complication
[ ] (UMLS (ICD9CM) C0157667) =Disease or Syndrome
86. Gallbladder Polyp
(UMLS (NCI) C0262493) =Neoplastic Process
37. Galactorrhea, postpartum condition or complication
[ ] (UMLS (ICD9CM) C0157668) =Disease or Syndrome
87. Gallbladder Rhabdomyosarcoma
[A malignant mesenchymal tumor with skeletal muscle differentiation affecting the gallbladder. ( NCI )] (UMLS (NCI) C1333756) Rhabdomyosarcoma of Gallbladder;
Rhabdomyosarcoma of the Gallbladder =Neoplastic Process
38. Galactorrhea, with delivery, with mention of postpartum complication
[ ] (UMLS (ICD9CM) C0157666) =Disease or Syndrome
88. Gallbladder Sarcoma
(UMLS (NCI) C1333757) Sarcoma of Gallbladder;
Sarcoma of the Gallbladder =Neoplastic Process
39. Galactorrhea, with delivery, with or without mention of antepartum condition
[ ] (UMLS (ICD9CM) C0157665) =Disease or Syndrome
89. Gallbladder Signet Ring Cell Carcinoma
(UMLS (NCI) C1333758) Signet Ring Cell Carcinoma of Gallbladder;
Signet Ring Cell Carcinoma of the Gallbladder =Neoplastic Process
40. galactosamine
[amino sugar derivative of galactose, substituted at the 2 position; occurs in a variety of glycosaminoglycans and complex polysaccharides, such as blood group substances, and is generally acetylated. ( CSP )] (UMLS (CSP) C0016943) =Carbohydrate; Biologically Active Substance =Hexosamines;
90. Gallego
(UMLS (HL7) C1553364) =Population Group =Spaniard;
41. galactose
[aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. ( CSP )] (UMLS (CSP) C0016945) =Carbohydrate; Indicator, Reagent, or Diagnostic Aid =hexose;
Inactive Ingredient Preparations =LACTULOSE 10 GM;
LACTULOSE 20 GM/PACKET Oral (systemic) powder for suspension;
Galactose 147 MG/ML;
91. Gallium nitrate
[A drug that lowers blood calcium. Used as treatment for hypercalcemia (too much calcium in the blood) and for cancer that has spread to the bone (bone metastases). ( NCI )] (UMLS (NCI) C0061008) =Pharmacologic Substance; Inorganic Chemical ;
42. galactose 1 phosphate uridylyl transferase deficiency
[ ] (UMLS (CSP) C0268151) =Disease or Syndrome ;
92. Gallium Nitrate/Hydroxyurea
(UMLS (NCI) C0281535) =Therapeutic or Preventive Procedure
43. galactose 1 phosphate uridylyltransferase
[An enzyme that catalyzes the synthesis of UDPgalactose from UTP and galactose-1-phosphate. It is present in low levels in fetal and infant liver, but increases with age, thereby enabling galactosemic infants who survive to develop the capacity to metabolize galactose. EC ( MSH )] (UMLS (CSP) C0016953) =Amino Acid, Peptide, or Protein; Enzyme
93. Gallium Nitrate/Ifosfamide/Vinblastine
(UMLS (NCI) C0281471) =Therapeutic or Preventive Procedure
44. Galactose Metabolism
[The chemical reactions and pathways involving galactose, the aldohexose galacto-hexose. D-galactose is widely distributed in combined form in plants, animals and microorganisms as a constituent of oligo- and polysaccharides; it also occurs in galactolipids and as its glucoside in lactose and melibiose. [ISBN:0198506732 "Oxford Dictionary of Biochemistry and Molecular Biology"] ( GO )] (UMLS (NCI) C1156458) Galactose Metabolism Pathway;
=Molecular Function
94. Gallium Nitrate/Paclitaxel
(UMLS (NCI) C0281635) =Therapeutic or Preventive Procedure
45. galactose oxidase
[An enzyme that oxidizes galactose in the presence of molecular oxygen to D-galacto-hexodialdose. It is a copper protein. EC ( MSH )] (UMLS (CSP) C0016948) =Amino Acid, Peptide, or Protein; Enzyme =alcohol oxidoreductase;
95. Gallium Scan
[A nuclear imaging procedure in which gallium-67 is used as the radiopharmaceutical. Gallium binds to transferrin, leukocyte lactoferrin, bacterial siderophores and inflammatory proteins and thereby can be used to localize foci of infection. It is also taken up by several tumors, thus gallium scintigraphy can be used for the staging of tumors. ( NCI )] (UMLS (NCI) C0521316) =Diagnostic Procedure
46. galactosemia
[group of inherited enzyme deficiencies which feature elevations of galactose in the blood; this condition may be associated with deficiencies of galactokinase, UDP glucose-hexose-1-phosphate uridylyltransferase (classic form), or UDP glucose 4-epimerase; the classic form presents in infancy with failure to thrive, vomiting, and intracranial hypertension; affected individuals also may develop mental retardation, jaundice, hepatosplenomegaly, ovarian failure and cataracts. ( CSP )] (UMLS (CSP) C0016952) =Disease or Syndrome ;
=Carbohydrate Metabolism, Inborn Errors;
enzyme deficiency;
Brain Diseases, Metabolic, Inborn;
96. gallon (Queen Anne's wine gallon)
[231 [in_i]3 ( HL7V3.0 )] (UMLS (HL7) C1552932) =Quantitative Concept =UnitOfMeasureAtomInsens;
47. galactoside
[glycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of galactose with an alcohol to form an acetal. ( CSP )] (UMLS (CSP) C0016956) =Carbohydrate ;
[ ] (UMLS (ICD9CM) C0156156) =Disease or Syndrome ;
48. Galactosyltransferase
[nonEC. ( CSP )] (UMLS (NCI) C0016964) =Amino Acid, Peptide, or Protein; Enzyme =hexosyltransferase;
98. GalNAc(beta 1->4)-[NeuAc(alpha 2->8)NeuAc(alpha 2->3)]Gal(beta 1->4)GlcCer
[A cell surface antigen expressed on all tumors of neuroectodermal origin, including melanoma, neuroblastomas, sarcoma, astrocytomas, and small cell lung cancer. GD2 is an O-acetylated disialoganglioside, belongs to the group of glycosphingolipids that are widely expressed in many tissues and organs in vertebrates and have been suggested to be involved in the regulation of development and differentiation as recognition molecules or signal modulators. Due to its high level of expression in neuroblastoma, GD2 has potential to be used as a component of anti-neuroblastoma vaccines, in addition to be used in polyvalent anti-melanoma vaccines ( NCI )] (UMLS (NCI) C0061104) =Lipid
49. galanin
[widely distributed in the central and peripheral nervous systems; modulates pituitary, pancreatic, and gastric hormone secretions; functional antagonist of cholinergic neurotransmission. ( CSP )] (UMLS (CSP) C0060993) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
99. GALT
[Non-encapsulated accumulations of lymphoid tissue in the alimentary tract that form a secretory immune system containing cells committed to IgA or IgE synthesis; It includes Peyer's patches and the lymphoid tissue which is present throughout the gastrointestinal mucosa. ( NCI )] (UMLS (NCI) C0596638) =Tissue ;
=secretory immune system;
=Peyer's Patch;
50. Galanin Receptor 2
[Galanin Receptor 2 (GALR2) is encoded by the GALR2 gene. Galanin is an important neuromodulator, a 30-amino acid non-C-terminally amidated peptide that potently stimulates growth hormone secretion, inhibits cardiac vagal slowing of heart rate, abolishes sinus arrhythmia, and inhibits postprandial gastrointestinal motility. The actions of galanin are mediated through interaction with specific G protein-coupled receptors. GALR2 interacts with the N-terminal residues of the galanin peptide. Galanin Receptor 2 decreases cAMP through an inhibitory G-protein and stimulates phospholipase C and mobilizes calcium through Gq/G11. The primary signaling mechanism for GALR2 is through the phospholipase C/protein kinase C pathway (via Gq). (From LocusLink and NCI) ( NCI )] (UMLS (NCI) C0630195) =Amino Acid, Peptide, or Protein; Receptor
100. galvanometry
[ ] (UMLS (CSP) C0598235) =Laboratory Procedure ;

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.

 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM